AAAAAA
Results:
1-17
|
Results: 17
Authors:
Eger, K
Zierz, S
Citation: K. Eger et S. Zierz, Limb-girdle muscular dystrophy, DEUT MED WO, 126(22), 2001, pp. 655-658
Authors:
Hess, S
Akermann, MA
Wnendt, S
Zwingerberger, K
Eger, K
Citation: S. Hess et al., Synthesis and immunological activity of water-soluble thalidomide prodrugs, BIO MED CH, 9(5), 2001, pp. 1279-1291
Authors:
Gutschow, M
Hecker, T
Thiele, A
Hauschildt, S
Eger, K
Citation: M. Gutschow et al., Aza analogues of thalidomide: Synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro, BIO MED CH, 9(4), 2001, pp. 1059-1065
Authors:
Hess, S
Teubert, U
Ortwein, J
Eger, K
Citation: S. Hess et al., Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance, EUR J PH SC, 14(4), 2001, pp. 301-311
Authors:
Hess, S
Akermann, M
Ropte, D
Eger, K
Citation: S. Hess et al., Rapid and sensitive LC separation of new impurities in trimethoprim, J PHARM B, 25(3-4), 2001, pp. 531-538
Authors:
Eschke, D
Brand, A
Scheibler, P
Hess, S
Eger, K
Allgaier, C
Nieber, K
Citation: D. Eschke et al., Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole onmembrane properties and neurotransmitter release in rat cortical and hippocampal neurons, NEUROCHEM I, 38(5), 2001, pp. 391-398
Authors:
Hess, S
Dolker, M
Haferburg, D
Kertscher, HP
Matysik, FM
Ortwein, J
Teubert, U
Zimmermann, W
Eger, K
Citation: S. Hess et al., Separation, analyses and syntheses of trimethoprim impurities, PHARMAZIE, 56(4), 2001, pp. 306-310
Authors:
Witt, UG
Schultz, JE
Dolker, M
Eger, K
Citation: Ug. Witt et al., Inhibition of protein phosphatases by Michael adducts of ascorbic acid analogues with alpha,beta-unsaturated carbonyl compounds, BIO MED CH, 8(4), 2000, pp. 807-813
Authors:
Wieser, T
Bonsch, D
Eger, K
Schulte-Mattler, W
Zierz, S
Citation: T. Wieser et al., A family with PROMM not linked to the recently mapped PROMM locus DM2, NEUROMUSC D, 10(2), 2000, pp. 141-143
Authors:
Fathi, AR
Krautheim, A
Kaap, S
Eger, K
Steinfelder, HJ
Citation: Ar. Fathi et al., Michael adducts of ascorbic acid as inhibitors of protein phosphatase 2A and inducers of apoptosis, BIOORG MED, 10(14), 2000, pp. 1605-1608
Authors:
Thiele, A
Thormann, M
Hofmann, HJ
Naumann, WW
Eger, K
Hauschildt, S
Citation: A. Thiele et al., A possible role of N-cadherin in thalidomide teratogenicity, LIFE SCI, 67(4), 2000, pp. 457-461
Authors:
Hess, S
Muller, CE
Frobenius, W
Reith, U
Klotz, KN
Eger, K
Citation: S. Hess et al., 7-deazaadenines bearing polar substituents: Structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists, J MED CHEM, 43(24), 2000, pp. 4636-4646
Authors:
Wormstadt, F
Brinckmann, U
Gutschow, M
Eger, K
Citation: F. Wormstadt et al., Synthesis of acyclic nucleoside phosphonates as antiviral compounds, J HETERO CH, 37(5), 2000, pp. 1187-1191
Authors:
Eger, K
Bretschneider, F
Zierz, S
Lehmann-Horn, F
Citation: K. Eger et al., Muscle diseases - New developments, AKT NEUROL, 26(5), 1999, pp. 204-214
Authors:
Gutschow, M
Hecker, T
Eger, K
Citation: M. Gutschow et al., A new one-pot synthesis of 5,5-disubstituted hydantoins from diethyl acetamidomalonates and ureas, SYNTHESIS-S, (3), 1999, pp. 410-414
Authors:
Gutschow, M
Kuerschner, L
Neumann, U
Pietsch, M
Loser, R
Koglin, N
Eger, K
Citation: M. Gutschow et al., 2-(diethylamino)thieno[1,3]oxazin-4-ones as stable inhibitors of human leukocyte elastase, J MED CHEM, 42(26), 1999, pp. 5437-5447
Authors:
Weber, W
Jager, J
Dolker, M
Eger, K
Citation: W. Weber et al., First synthesis of the main metabolite of secobarbital, PHARMAZIE, 53(11), 1998, pp. 771-775
Risultati:
1-17
|